Vera Therapeutics Statistics
Total Valuation
VERA has a market cap or net worth of $1.45 billion. The enterprise value is $912.30 million.
Important Dates
The last earnings date was Tuesday, May 6, 2025, before market open.
Earnings Date | May 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
VERA has 63.77 million shares outstanding. The number of shares has increased by 27.09% in one year.
Current Share Class | 63.77M |
Shares Outstanding | 63.77M |
Shares Change (YoY) | +27.09% |
Shares Change (QoQ) | +4.91% |
Owned by Insiders (%) | 0.82% |
Owned by Institutions (%) | 92.69% |
Float | 50.49M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.71 |
P/TBV Ratio | 2.71 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 27.68, with a Debt / Equity ratio of 0.10.
Current Ratio | 27.68 |
Quick Ratio | 27.10 |
Debt / Equity | 0.10 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -25.73 |
Financial Efficiency
Return on equity (ROE) is -39.49% and return on invested capital (ROIC) is -24.25%.
Return on Equity (ROE) | -39.49% |
Return on Assets (ROA) | -23.46% |
Return on Invested Capital (ROIC) | -24.25% |
Return on Capital Employed (ROCE) | -32.85% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.57M |
Employee Count | 112 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, VERA has paid $1,000 in taxes.
Income Tax | 1,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.88% in the last 52 weeks. The beta is 1.13, so VERA's price volatility has been higher than the market average.
Beta (5Y) | 1.13 |
52-Week Price Change | -44.88% |
50-Day Moving Average | 22.75 |
200-Day Moving Average | 34.91 |
Relative Strength Index (RSI) | 47.79 |
Average Volume (20 Days) | 2,555,783 |
Short Selling Information
The latest short interest is 7.07 million, so 11.08% of the outstanding shares have been sold short.
Short Interest | 7.07M |
Short Previous Month | 5.96M |
Short % of Shares Out | 11.08% |
Short % of Float | 14.00% |
Short Ratio (days to cover) | 6.17 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -193.25M |
Pretax Income | -107.85M |
Net Income | -175.46M |
EBITDA | -193.07M |
EBIT | -193.25M |
Earnings Per Share (EPS) | -$3.00 |
Full Income Statement Balance Sheet
The company has $589.83 million in cash and $54.47 million in debt, giving a net cash position of $535.37 million or $8.39 per share.
Cash & Cash Equivalents | 589.83M |
Total Debt | 54.47M |
Net Cash | 535.37M |
Net Cash Per Share | $8.39 |
Equity (Book Value) | 535.00M |
Book Value Per Share | 8.39 |
Working Capital | 584.18M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$155.26 million and capital expenditures -$1.16 million, giving a free cash flow of -$156.41 million.
Operating Cash Flow | -155.26M |
Capital Expenditures | -1.16M |
Free Cash Flow | -156.41M |
FCF Per Share | -$2.45 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
VERA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -27.09% |
Shareholder Yield | -27.09% |
Earnings Yield | -12.12% |
FCF Yield | -10.80% |
Dividend Details Analyst Forecast
The average price target for VERA is $64.63, which is 184.71% higher than the current price. The consensus rating is "Buy".
Price Target | $64.63 |
Price Target Difference | 184.71% |
Analyst Consensus | Buy |
Analyst Count | 8 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |